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Plasma membrane blebs are observed in many types of apoptotic cells, but their physio-
logical roles remain to be clarified. We examined whether there is a causative connec-
tion between membrane blebbing and other apoptotic changes in Jurkat cells induced
to undergo apoptosis by doxorubicin in the presence or absence of Y-27632, an inhibitor
of the Rho kinase ROCK-L The inclusion of the drug made most membrane blebs disap-
pear, while other changes, such as chromatin condensation, inactivation of mitochon-
drial enzymes, externalization of the membrane phospholipid phosphatidylserine, and
removal of cell surface sialic acid, remained unaffected. Furthermore, these apoptotic
cells were phagocytosed by macrophages as efficiently as normally apoptosing cells.
These results indicate that blebbing of the plasma membrane occurs independently
from other apoptotic changes and is not involved in the recognition and engulfment of
apoptotic cells by macrophages.
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Apoptotic cells are rapidly and selectively eliminated from
organisms, and this event is necessary for the maintenance
of tissue homeostasis (1-8). The phagocytic removal of apo-
ptotic cells is accomplished through an array of distinct bio-
logical reactions: migration of phagocytes to the place
where apoptotic cells exist, selective recognition and engulf-
ment of target cells by phagocytes, and digestion of en-
gulfed apoptotic cells in phagocytes. Although the impor-
tance of this phenomenon is widely accepted, the underly-
ing molecular bases remain mostly unknown.
Among the reactions listed above, the recognition step
has been most intensively studied. The surface of apoptotic
cells changes structurally and functionally in order for
them to be efficiently and selectively recognized by phago-
cytes (9-11). The most obvious change occurs in the compo-
sition of phospholipids in the plasma membrane. Phospho-
lipids are distributed asymmetrically in the two leaflets of
the membrane bilayer in normal cells (12, 13), but this
asymmetry is disrupted in apoptotic cells through a
caspase-dependent mechanism, resulting in the equal dis-
tribution of phospholipids in the two leaflets (14, 15). This
change leads to the surface exposure of phospholipids that
are otherwise hidden within the cytoplasmic face; phos-
phatidylserine (PS) is one such phospholipid specifically
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present at the surface of apoptotic cells and serves as a
phagocytosis marker that binds to phagocytes and induces
engulfment (14-16). Phagocytosis-inducing PS receptors
have been identified in various phagocytes such as vascular
en-dothelial cells (17), testicular Sertoli cells (18), and
inflammatory macrophages (19).
Another change commonly observed at the surface of
apoptotic cells is membrane blebbing, a more obvious struc-
tural alteration of the plasma membrane. Distinct parts of
the membrane of apoptotic cells begin to swell, and apop-
totic cells eventually look like raspberries with many
"blebs" on their surface (20). Plasma membrane blebs are
thought to serve as the sites for binding of functional mole-
cules such as antigens (21-24) and phagocytosis markers
(25), and might thus be involved in the recognition and
engulfment of apoptotic cells by phagocytes. Although the
detailed molecular basis for the formation of blebs remains
unknown, the involvement of caspases and a Rho protein
kinase, ROCK-I (26, 27), has been reported (28-30). In the
present study, we examined the relationship between plas-
ma membrane blebbing and other biochemical and biologi-
cal changes observed in apoptotic cells using the ROCK-I
inhibitor Y-27632 (31, 32).
MATERIALS AND METHODS
Cell Culture and Apoptosis Analysis—Jurkat cells, hu-
man leukemia T-cells, were grown in RPMI 1640 (Nissui
Pharmaceutical, Tokyo) containing 10% fetal bovine serum
at 37°C in a humidified atmosphere of 5% CO2 in air. The
cells were treated with doxorubicin (Sigma, St. Louis, MO,
USA) (1.5 jjLg/ml) to induce apoptosis as described previ-
ously (33). To inhibit apoptosis, the pan-caspase inhibitor
z-VAD-fink (Peptide Institute, Osaka, Japan) (20 \xM) was
added to the culture 1 h before doxorubicin treatment. The
occurrence of membrane blebbing was determined morpho-
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logically by phase-contrast microscopy. For the inhibition of
membrane Webbing, cells were pre-treated with Y-27632 (a
gift from Mitsubishi Welpharma, Tokyo) 1 h before the in-
duction of apoptosis. Plasma membrane permeability, the
activity of mitochondrial enzymes, chromatin condensation,
and DNA fragmentation were determined by standard pro-
cedures: a dye exclusion assay with trypan blue, an enzyme
assay using 3-(4,5-dimethyl-2-thyazolyl)-2,5-diphenyl-2H-
tetrazolium bromide (Dojin, Kumamoto) (MTT assay),
staining with Hoechst 33342, and agarose gel electrophore-
sis, respectively (33). PS externalization and the loss of cell
surface sialic acid were examined by flow cytometry
(EPICS-XL; Beckman Coulter, Miami, FL, USA) using fluo-
rescence-labeled annexin V and sialic acid-recognizing lec-
tins, respectively (34, 35). Briefly, cells were incubated with
fluorescein isothiocyanate (FlTC)-labeled annexin V (Bend-
er MedSystems, Vienna, Austria) (36, 37) or FITC-labeled
lectin [wheat germ agglutinin (WGA), Maackia amurensis
lectin (MAM), or Sambucus sieboldiana lectin (SAS)]
(Honen Corporation, Tokyo) in the presence of propidium
iodide, and the cells that were less intensely stained with
propidium iodide were gated and analyzed for the binding
of FITC-annexin V or FTTC-lectin.
Western Blotting—Jurkat cells were lysed in a buffer con-
taining 50 mM Tris-HCl (pH 7.5), 1% Triton X-100, 0.1 M
NaCl, and a protease inhibitor cocktail (Sigma), incubated
on ice for 30 min, and centrifuged at 18,000 xg for 10 min
at 4°C. The solubilized proteins were electrophoretically
separated on a 10% SDS—polyacrylamide gel and trans-
ferred onto a polyvinylidene difluoride membrane (Tmmn-
bilon P; Millipore, Bedford, MA, USA). The membrane was
blocked with 5% dry skim milk, reacted successively with
anti-human ROCK-I antibody (C-17 or K-18; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and alkaline phos-
phatase-conjugated anti-goat IgG (Bio-Rad Laboratories,
Hercules, CA, USA), and chemiluminescently analyzed for
signals using Immun-Star substrates (Bio-Rad). To exam-
ine the specificity of the antibody reactions, the first anti-
body was pre-incubated with an excess amount of the cor-
responding antigen peptide (Santa Cruz Biotechnology).
Macrophage Preparation and Phagocytosis Assay—Mac-
rophages were prepared from peritoneal fluids of thioglycol-
late-injected BDFX mice (female, 8-12 weeks old) and cul-
tivated on coverslips until use as described previously (33,
38). The phagocytosis assay was performed essentially as
described (33, 38). Briefly, apoptotic Jurkat cells were
mixed with macrophages at a ratio of 10 target cells to one
macrophage, and incubated at 37°C for various lengths of
time. The mixture was treated with trypsin to remove tar-
get cells lightly attached to macrophages. The remaining
macrophages were fixed with paraformaldehyde, permeabi-
lized with methanol, and stained with hematoxylin. The
numbers of macrophages with engulfed Jurkat cells and
the number of engulfed cells present in each macrophage
were determined by examination under a light microscope.
The scores were expressed relative to the total number of
macrophages (in percentage; the phagocytdc index) and per












Fig. 1. Inhibition of membrane
blebbing by Y-27632 in doxorubi-
cin-treated thirkat cells. A: Jurkat
cells were induced to undergo apop-
toais by doxorubicin with or without
1-h pre-treatment with z-VAD-fmk
and/or Y-27632 (100 jiM except for
the right panel), and the number of
cells containing plasma membrane
blebs was determined by microscopic
examination. In the middle panel,
the number of cells with blebs is
shown relative to the number of cells
with blebs in the absence of inhibitor
at time 50 h, taken as 100. In the
right panel, cells were pre-incubated
with Y-27632 at various concentra-
tions and then treated with doxoru-
bicin for the indicated periods. B:
Jurkat cells treated or not treated
with Y-27632 for 1 h were incubated
in the presence or absence of doxo-
rubicin for 24 h and stained with
Hoechst 33342. Phase contrast and
fluorescence/phase contrast views of
the same fields are shown. Bar = 10
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typical example from at least three independent experi-
ments. Iiposomes composed of a combination of phosphati-
dylchohne and PS at a ratio of 7:3 were prepared as de-
scribed previously (34).
RESULTS
Inhibition of Membrane Blebbing by ROCK-I Inhibitor Y-
27632—Jurkat cells were induced to undergo apoptosis by
treatment with doxorubicin and examined for the occur-
rence of plasma membrane blebbing (Fig. 1). Distinct parts
of the cell periphery protruded like balloons (Fig. IB) which
became evident 18 h after doxorubicin addition and contin-
ued to increase thereafter (left panel in Fig. 1A). These
results indicate that treatment with doxorubicin effectively
induces plasma membrane blebbing in Jurkat cells. This
change in the structure of the plasma membrane almost
completely disappeared when Jurkat cells were incubated
with the pan-caspase inhibitor z-VAD-fmk prior to the
addition of doxorubicin (middle panel in Fig. 1A). Further-
more, the ROCK-I inhibitor Y-27632 showed a similar in-
hibitory effect on membrane blebbing in a dose-dependent
manner (middle and right panels in Fig. 1A and Fig. IB).
These results indicate that plasma membrane blebbing in
apoptotic Jurkat cells depends on the activity of both
caspases and ROCK-I, and this accords well with previous
observations using other types of cells and apoptosis induc-
ers (29, 30, 39-41).
ROCK-I is activated by the caspase-mediated cleavage of
its C-terminal region in apoptotic cells (29, 30). In order to
verify that this occurs in doxorubicin-treated Jurkat cells,
whole-cell lysates were analyzed by Western blotting with
anti-ROCK-I antibody (Fig. 2). A signal with a molecular
mass of about 160 kDa was detected, and its intensity de-
creased during apoptosis (top panel in Fig. 2A). This signal
resulted from the specific reaction with the antibody, since
the inclusion of the corresponding antigen peptide in the
antibody reaction completely eliminated the signal (bottom
panel in Fig. 2A). These results indicate that the amount of
the intact form of ROCK-I decreases during apoptosis, most
probably due to cleavage by caspases. This change was
abrogated, though incompletely, by the addition of z-VAD-
fmk (top panel in Fig. 2B), but, unexpectedly, ROCK-I ap-
peared to be cleaved after the induction of apoptosis even in
cells pre-treated with Y-27632 (bottom panel in Fig. 2B).
These results conflict with previous observations that
ROCK-I does not undergo cleavage in the presence of Y-
27632 (29, 30), and suggest that the inhibition of plasma
membrane blebbing by Y-27632 is achieved through a
mechanism other than interference with the activation of
ROCK-I.
No Effect of Y-27632 on Other Biochemical Apoptotic
Changes—We examined whether or not the presence of Y-
27632 inhibits other biochemical apoptotic changes in doxo-
rubicin-treated cells. The condensation of chromatin (Fig.
IB and Fig. 3A), inactivation of mitochondrial enzymes
(Fig. 3B), and externalization of PS (Fig. 3C) all occurred
normally even in the presence of Y-27632. In addition, the
drug did not affect the removal of cell surface sialic acid,
which was evident from a decrease in the amount of sialic
acid-recognizing lectins bound to cells. Essentially the same
results were obtained with three different lectins, WGA,
MAM, and SAS (Fig. 3D).
No Effect of Membrane Blebbing on Susceptibility to
Phagocytosis—We previously reported that doxorubicin-
treated Jurkat cells are phagocytosed by thioglycoilate-
induced mouse peritoneal macrophages in a manner partly
mediated by PS expressed on the surface of target cells
during apoptosis (33). The removal of cell surface sialic
acid, another change that occurs at the surface of apoptotic
cells, has been shown to be necessary for efficient phagocy-
tosis (35). We therefore examined whether or not the pres-
ence of plasma membrane blebs is involved in the phago-
cytosis of apoptotic cells by macrophages. To do so, the
phagocytosis assay was conducted with Jurkat cells that
had been induced to undergo apoptosis by doxorubicin with
and without Y-27632 pre-treatment (Fig. 4). The extent of
phagocytosis was determined based on the ratio of mac-
rophages that accomplished phagocytosis or on the number
of engulfed cells in each macrophage. Cells pre-treated with
Y-27632 were phagocytosed with a time course and effi-
ciency similar to those of normally apoptosing cells using
either criterion (Fig. 4A). Phagocytosis was partly inhibited
by the addition of PS-containing Iiposomes, and the extent
of inhibition was almost equal in reactions with apoptotic
Jurkat cells treated or not treated with Y-27632 (Fig. 4B).
This indicates that plasma membrane blebbing is not
involved in phagocytosis either mediated or not mediated
by cell surface PS.
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Fig. 2. Cleavage of ROCK-I during apoptosis. A: (top) Whole-cell
lysates of Jurkat cells treated or not treated with doxorubicin for the
indicated periods were analyzed by Western blotting with anti-
ROCK-I antibody. The position of a 160-kDa signal is indicated by
the arrowhead, (bottom) The reaction with anti-ROCK-I antibody
was performed in the presence or absence of the corresponding anti-
gen peptide (ROCK-I) or a peptide with an unrelated sequence B:
Jurkat cells were pre-treated for 1 h with z-VAD-fink or Y-27632 (100
|j.M) prior to the addition of doxorubicin and analyzed after 18 h (top)
or 24 h (bottom) as in (A).
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Fig. 3. No effect of Y-27632 on other apoptotic
changes. Jurkat cells were pre-treated for 1 h
with Y-27632 (at 100 JJLM or the indicated concen-
trations) and/or z-VAD-fink, incubated in the pres-
ence or absence (indicated by the symbol 'none') of
doxorubicin, and analyzed for the occurrence of ap-
optotic changes. A; Cells incubated in the presence
or absence of doxorubicin (DXR) for the indicated
periods were treated with Hoechst 33342 and ex-
amined for the presence of intensely stained nu-
clei. B: Cells incubated in the presence or absence
of doxorubicin (DXR) were subjected to the MTT
assay, and the level of mitochondrial enzyme activ-
ity is expressed relative to that of normal cells,
taken as 100. C: Cells incubated for 24 h in the
presence or absence of doxorubicin were examined
for PS externalization by flow cytometry. Cells less
intensely stained with propidium iodide (bottom
area in the left panels) were analyzed for the bind-
ing of FTTC-annexin V (right panels). The numbers
indicate the ratios of cells (in percentage) in the
corresponding areas. D: Cells were incubated for
24 h in the presence or absence of doxorubicin and
examined for the binding of FITC-labeled WGA,
MAM, or SAS by flow cytometry. The vertical lines




Plasma membrane blebbing is one of the hallmarks of apo
ptosis, but its mechanism and physiological consequences
remain to be elucidated. In the present study, we examined
whether there is a causative connection between mem-
brane blebbing and other intracellular as well as surface
changes evident during apoptosis. For this purpose, chro-
matdn condensation, inactivation of mitochondrial en-
zymes, PS externalization, and cell surface desialylation
were determined in apoptotic Jurkat cells treated with a
drug that completely inhibits plasma membrane blebbing.
We found that all of these biochemical changes occurred in
apoptotic cells with no blebs on the plasma membrane. This
clearly indicates that plasma membrane blebbing does not
occur upstream of these changes in the apoptotic pathway.
Both caspase-dependent and -independent mechanisms
seem to be responsible for blebbing of the plasma mem-
brane (29, 30, 40-44). Our results show that the appear-
ance of membrane blebs in doxorubicin-treated Jurkat cells
depends on caspases and is completely inhibited by the
ROCK-I inhibitor Y-27632. However, the cleavage of ROCK-
I, which reportedly leads to the activation of this protein
kinase, was evident even in the presence of Y-27632. This
was also the case when another apoptosis inducer, an ago-
nistic anti-Fas antibody, was used to kill Jurkat cells (data
not shown). Given that Y-27632 specifically targets ROCK-
I, the drug might abrogate the function of ROCK-I not by
inhibiting the partial cleavage in the inactive precursor, but
by inhibiting the action of the cleaved and thus activated
ROCK-I. However, this is only speculative, and further
studies are needed to resolve the issue.
Plasma membrane blebbing is a change that occurs at
the surface of apoptotic cells in addition to alterations in
the composition of phospholipids and the structure of sugar
moieties. Among the surface changes reported so far, PS
externalization and desialylation make apoptotic cells more
susceptible to phagocytosis, an important biological con-
sequence of apoptosis. Inhibition of plasma membrane
blebbing did not influence the extent of either PS external-
ization or desialylation, indicating that the latter two
J. Biochem.
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Fig. 4. Efficient phagocytosis by macrophages of apoptotic cells
with no membrane blebs. Jurkat cells induced to undergo apopto-
sis by doxorubicin for 24 h with or without 1-h pre-treatment withY-
27632 were subjected to the phagocytosis assay with mouse perito-
neal macrophages. A; Time course of phagocytosis reaction. The
phagocytic index (top) and number of engulfed cells per 100 mac-
rophages (bottom) were determined at the indicated time points of
the phagocytosis reaction. B: Effect of PS-containing liposomes.
Phagocytosis reactions were conducted for 2 h in the presence or ab-
sence of PS-containing liposomes (1 mM). The phagocytic index (top)
and the number of engulfed cells (bottom) are shown relative to reac-
tions with no added liposomes, taken as 100. The means of the
phagocytic index and the number of engulfed cells in control reac-
tions were 34 (without Y-27632) and 27 (with Y-27632), and 26 (with-
out Y-27632) and 23 (with Y-27632), respectively.
changes occurring at the surface of apoptotic cells are unre-
lated to membrane blebs. Furthermore, apoptotic Jurkat
cells with and without membrane blebs were equally
phagocytosed by macrophages, and the addition of PS-con-
taining liposomes inhibited phagocytosis of apoptotic Jur-
kat cells treated or not treated with Y-27632 to similar
extents. These results indicate that plasma membrane
blebs are not involved in phagocytosis either mediated or
not mediated by PS. The PS-independent reactions in our
assay do not seem to require factors present in serum,
because the efficiency of phagocytosis was the same for re-
actions with and without serum (data not shown). There-
fore, it remains possible that membrane blebs play a role in
complement- or Fc-mediated recognition of apoptotic cells
by phagocytes. In fact, Clq preferentially binds to apoptotic
cells at plasma membrane blebs (45). Apart from phagocy-
tosis, membrane blebs could be involved in the transmis-
sion of signals from apoptotic cells to their neighbors, as
shown with apoptotic epithelial cells extruded from the epi-
thelium {46). Further studies from various points of view
will be necessary to clarify the physiological consequences
of plasma membrane blebbing.
We thank Mitsubishi Welpharma for Y-27632.
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